APA (7th ed.) Citation

YC, H., MH, N., & CY, W. (2023). Letter: Safety after cessation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B infection-Authors' reply. Alimentary pharmacology & therapeutics, 58(7), 733. https://doi.org/10.1111/apt.17681

Chicago Style (17th ed.) Citation

YC, Hsu, Nguyen MH, and Wu CY. "Letter: Safety After Cessation of Nucleos(t)ide Analogue Therapy in Patients with Chronic Hepatitis B Infection-Authors' Reply." Alimentary Pharmacology & Therapeutics 58, no. 7 (2023): 733. https://doi.org/10.1111/apt.17681.

MLA (9th ed.) Citation

YC, Hsu, et al. "Letter: Safety After Cessation of Nucleos(t)ide Analogue Therapy in Patients with Chronic Hepatitis B Infection-Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 58, no. 7, 2023, p. 733, https://doi.org/10.1111/apt.17681.